Solid Biosciences (SLDB) Invested Capital: 2017-2024
Historic Invested Capital for Solid Biosciences (SLDB) over the last 7 years, with Sep 2024 value amounting to $170.4 million.
- Solid Biosciences' Invested Capital rose 18.05% to $170.4 million in Q3 2024 from the same period last year, while for Sep 2024 it was $170.4 million, marking a year-over-year increase of 18.05%. This contributed to the annual value of $126.5 million for FY2023, which is 40.25% down from last year.
- Per Solid Biosciences' latest filing, its Invested Capital stood at $170.4 million for Q3 2024, which was down 11.81% from $193.2 million recorded in Q2 2024.
- Solid Biosciences' Invested Capital's 5-year high stood at $253.0 million during Q1 2021, with a 5-year trough of $22.2 million in Q3 2020.
- Its 3-year average for Invested Capital is $172.3 million, with a median of $170.4 million in 2024.
- Its Invested Capital has fluctuated over the past 5 years, first tumbled by 79.52% in 2020, then soared by 904.74% in 2021.
- Solid Biosciences' Invested Capital (Quarterly) stood at $132.1 million in 2020, then soared by 57.63% to $208.2 million in 2021, then grew by 1.66% to $211.7 million in 2022, then crashed by 40.25% to $126.5 million in 2023, then grew by 18.05% to $170.4 million in 2024.
- Its last three reported values are $170.4 million in Q3 2024, $193.2 million for Q2 2024, and $210.7 million during Q1 2024.